12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

MoxDuo IR morphine/oxycodone regulatory update

FDA's Anesthetic and Analgesic Drug Products Advisory Committee will meet on July 17 to discuss an NDA from QRxPharma for MoxDuo IR morphine/oxycodone to treat moderate to...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >